| Synonyms: | |
| Status: | Approved (2009) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | L01EX03 |
| UNII: | 7RN5DR86CK |
| InChI Key | CUIHSIWYWATEQL-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C21H23N7O2S |
| Molecular Weight | 437.53 |
| AlogP | 3.14 |
| Hydrogen Bond Acceptor | 8.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 5.0 |
| Polar Surface Area | 119.03 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 4.0 |
| Heavy Atoms | 31.0 |
| Primary Target | |
|---|---|
| fms related receptor tyrosine kinase 1 | |
| fms related receptor tyrosine kinase 4 | |
| kinase insert domain receptor |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Neoplasms | 4 | D009369 | ClinicalTrials |
| Neoplasms | 4 | D009369 | ClinicalTrials |
| Sarcoma | 3 | D012509 | ClinicalTrials |
| Carcinoma, Renal Cell | 3 | D002292 | ClinicalTrials |
| Ovarian Neoplasms | 3 | D010051 | ClinicalTrials |
| Ovarian Neoplasms | 3 | D010051 | ClinicalTrials |
| Carcinoma, Renal Cell | 3 | D002292 | ClinicalTrials |
| Sarcoma | 3 | D012509 | ClinicalTrials |
| Small Cell Lung Carcinoma | 2 | D055752 | ClinicalTrials |
| Neoplasms, Germ Cell and Embryonal | 2 | D009373 | ClinicalTrials |
| Carcinoma, Squamous Cell | 2 | D002294 | ClinicalTrials |
| Chondrosarcoma | 2 | D002813 | ClinicalTrials |
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Thyroid Neoplasms | 2 | D013964 | ClinicalTrials |
| Leukemia, Myeloid, Acute | 2 | D015470 | ClinicalTrials |
| Telangiectasia, Hereditary Hemorrhagic | 2 | D013683 | ClinicalTrials |
| Urinary Bladder Neoplasms | 2 | D001749 | ClinicalTrials |
| Glioma | 2 | D005910 | ClinicalTrials |
| Solitary Fibrous Tumors | 2 | D054364 | ClinicalTrials |
| Gastrointestinal Stromal Tumors | 2 | D046152 | ClinicalTrials |
| Lymphedema | 2 | D008209 | ClinicalTrials |
| Leiomyosarcoma | 2 | D007890 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 2 | D002289 | ClinicalTrials |
| Liposarcoma | 2 | D008080 | ClinicalTrials |
| Prostatic Neoplasms | 2 | D011471 | ClinicalTrials |
| Osteosarcoma | 2 | D012516 | ClinicalTrials |
| Fallopian Tube Neoplasms | 2 | D005185 | ClinicalTrials |
| Kidney Neoplasms | 2 | D007680 | ClinicalTrials |
| Uterine Cervical Neoplasms | 2 | D002583 | ClinicalTrials |
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Prostatic Neoplasms, Castration-Resistant | 2 | D064129 | ClinicalTrials |
| Lung Neoplasms | 2 | D008175 | ClinicalTrials |
| Melanoma | 2 | D008545 | ClinicalTrials |
| Pancreatic Neoplasms | 2 | D010190 | ClinicalTrials |
| Hemangiosarcoma | 2 | D006394 | ClinicalTrials |
| Sarcoma, Alveolar Soft Part | 2 | D018234 | ClinicalTrials |
| Gliosarcoma | 2 | D018316 | ClinicalTrials |
| Neuroendocrine Tumors | 2 | D018358 | ClinicalTrials |
| Dermatofibrosarcoma | 2 | D018223 | ClinicalTrials |
| Macular Degeneration | 2 | D008268 | ClinicalTrials |
| Peritoneal Neoplasms | 2 | D010534 | ClinicalTrials |
| Salivary Gland Neoplasms | 2 | D012468 | ClinicalTrials |
| Stomach Neoplasms | 2 | D013274 | ClinicalTrials |
| Urinary Bladder Neoplasms | 2 | D001749 | ClinicalTrials |
| Peritoneal Neoplasms | 2 | D010534 | ClinicalTrials |
| Corneal Neovascularization | 1 | D016510 | ClinicalTrials |
| Lymphoma | 1 | D008223 | ClinicalTrials |
| Psoriasis | 1 | D011565 | ClinicalTrials |
| Carcinoma, Hepatocellular | 1 | D006528 | ClinicalTrials |
| Colorectal Neoplasms | 1 | D015179 | ClinicalTrials |
| Glioblastoma | 1 | D005909 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 444731-52-6 |
| ChEBI | 71219 |
| ChEMBL | CHEMBL477772 |
| DrugBank | DB06589 |
| DrugCentral | 4118 |
| EPA CompTox | DTXSID8048733 |
| FDA SRS | 7RN5DR86CK |
| Guide to Pharmacology | 5698 |
| PubChem | 10113978 |
| SureChEMBL | SCHEMBL588608 |
| ZINC | ZINC000011617039 |